Ultram and Travatan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ultram (tramadol hydrochloride) and Travatan (travoprost). Common drug interactions include transient ischaemic attack among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Ultram and Travatan. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.

What is Travatan?

Travatan has active ingredients of travoprost. It is often used in glaucoma. eHealthMe is studying from 13,103 Travatan users. Check the latest studies of Travatan.

On Jul, 05, 2026

42 people who take Ultram and Travatan together, and have interactions are studied.

What are the common drug interactions of Ultram and Travatan, by gender? *:

female:

Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Renal failure (kidney dysfunction)
Urinary tract infection
Vision blurred
Activities of daily living impaired
Arthralgia (joint pain)
Asthenia (weakness)
Bone pain
Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
Cerebral infarction (less blood supply to brain resulting tissue damage)

male:

Chronic kidney disease
Enterocolitis infectious
Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
Multiple allergies (allergy to multiple agents)
Osteoporosis (bones weak and more likely to break)
Plasma cell myeloma (cancer that begins in plasma cells)
Pulmonary embolism (blockage of the main artery of the lung)
Skin cancer
Tendon rupture (tear of tendon)
Wound dehiscence (a surgical incision reopens either internally or externally)

What are the common drug interactions of Ultram and Travatan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)

60+:

Renal failure (kidney dysfunction)
Chronic kidney disease
Dizziness
Dyspnoea (difficult or laboured respiration)
Dysuria (painful or difficult urination)
Enterocolitis infectious
Eye haemorrhage (bleeding in the eye)
Fall
Febrile neutropenia (fever with reduced white blood cells)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 14.29%
Multiple Myeloma (cancer of the plasma cells): 5 people, 11.90%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 11.90%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 9.52%
High Blood Cholesterol: 4 people, 9.52%
Stress And Anxiety: 3 people, 7.14%
Nausea (feeling of having an urge to vomit): 3 people, 7.14%
High Blood Pressure: 3 people, 7.14%
Diabetes: 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ultram and Travatan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously